Cardio Diagnostics Holdings Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Cardio Diagnostics Holdings ha un patrimonio netto totale di $3.7M e un debito totale di $0.0, che porta il suo rapporto debito/patrimonio netto a 0%. Le sue attività totali e le sue passività totali sono rispettivamente $4.5M e $795.3K.

Informazioni chiave

Rapporto debito/patrimonio netto

US$0

Debito

Indice di copertura degli interessi	n/a
Contanti	US$1.98m
Patrimonio netto	US$3.69m
Totale passività	US$795.28k
Totale attività	US$4.48m

Aggiornamenti recenti sulla salute finanziaria

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Mar 01

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Nov 02

Recent updates

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Mar 01

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Nov 02

Analisi della posizione finanziaria

Passività a breve termine: Le attività a breve termine ( $2.6M ) di CDIO superano le sue passività a breve termine ( $308.7K ).

Passività a lungo termine: Le attività a breve termine di CDIO ( $2.6M ) superano le sue passività a lungo termine ( $486.6K ).

Storia e analisi del rapporto debito/patrimonio netto

Livello di debito: CDIO è esente da debiti.

Riduzione del debito: CDIO non aveva debiti 5 anni fa.

Bilancio

Analisi della pista di contanti

Per le società che in passato sono state mediamente in perdita, valutiamo se hanno almeno un anno di liquidità.

Pista di liquidità stabile: CDIO ha meno di un anno di cash runway in base al suo attuale free cash flow.

Previsione Cash Runway: CDIO ha meno di un anno di liquidità disponibile se il flusso di cassa libero continua a ridursi ai tassi storici del 51.6 % ogni anno

Cardio Diagnostics Holdings Salute del bilancio

Salute finanziaria criteri di controllo 4/6

Informazioni chiave

Aggiornamenti recenti sulla salute finanziaria

Cardio Diagnostics Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(a)(2)

Cardio Diagnostics Holdings Receives an Email Notice from the Listing Qualifications Staff of the Nasdaq Stock Market

Cardio Diagnostics Holdings Receives a Written Notice from the Nasdaq Stock Market

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

Recent updates

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Price target decreased by 57% to US$2.00

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Nov 15, 2024

Consensus revenue estimates decrease by 89%, EPS upgraded

New major risk - Market cap size

Consensus revenue estimates fall by 16%

Cardio Diagnostics Holdings Receives Written Notice from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement Under Nasdaq Listing Rule 5550(a)(2)

New major risk - Financial position

Cardio Diagnostics Holdings, Inc. Announces the Availability of its Clinical Tests at Family Medicine Specialists' Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois

Cardio Diagnostics Holdings, Inc. Announces Publication of Study Showing That Its PrecisionCHD Test Could Save Health Insurers over $113 Million Annually

Price target increased by 33% to US$8.00

Consensus EPS estimates upgraded to US$0.43 loss, revenue downgraded

Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 At the American College of Cardiology’s 73rd Annual Scientific Session

Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease

Cardio Diagnostics Holdings, Inc. Expands Heartrisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide Rollout

Consensus revenue estimates decrease by 48%, EPS upgraded

Cardio Diagnostics Holdings Unveils Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk

Cardio Diagnostics Holdings, Inc. Appoints Paul F. Burton as Independent Director, Chair of Nominating and Corporate Governance Committee and Member of Audit Committee

Cardio Diagnostics Holdings, Inc. Elects Paul F. Burton as Director

American Medical Association Is Reviewing Cardio Diagnostics Holdings, Inc.'s Integrated Epigenetic-Genetic Cardiovascular Medicine Tests for CPT PLA Codes

Consensus revenue estimates increase by 38%

Cardio Diagnostics Holdings Receives an Email Notice from the Listing Qualifications Staff of the Nasdaq Stock Market

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with Precisionchd Test, Published in the Journal of the American Heart Association

New major risk - Shareholder dilution

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Dec 04, 2023

Cardio Diagnostics Holdings, Inc., Annual General Meeting, Dec 04, 2023

Cardio Diagnostics Holdings Receives a Written Notice from the Nasdaq Stock Market

New major risk - Market cap size

Cardio Diagnostics Holding, Inc’S Actionable Clinical Intelligencetm (Aci) Platform Offers New Epigenetic and Genetic Insights to Inform Coronary Heart Disease Management

We Think Cardio Diagnostics Holdings (NASDAQ:CDIO) Can Afford To Drive Business Growth

High number of new and inexperienced directors

No independent directors

Companies Like Cardio Diagnostics Holdings (NASDAQ:CDIO) Are In A Position To Invest In Growth

No independent directors

Analisi della posizione finanziaria

Storia e analisi del rapporto debito/patrimonio netto

Bilancio

Analisi della pista di contanti

Scoprire le aziende sane